ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-10I9044
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Albumin as Excipient Market Outlook 2022
BUY CHAPTERS

Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-10I9044
Report
July 2025
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
Grifols S A
Octapharma AG
Hualan Bio
CBPO
Shanghai Raas
Kedrion S p A
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
Himedia
Takeda

Albumin (as Excipient) Market Size

In 2024, the global market size of Albumin (as Excipient) was estimated to be worth US$ 4882 million and is forecast to reach approximately US$ 7346 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.

Albumin (as Excipient) Market

Albumin (as Excipient) Market

Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The industry"s leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Albumin (as Excipient), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Albumin (as Excipient).
The Albumin (as Excipient) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Albumin (as Excipient) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Albumin (as Excipient) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Albumin (as Excipient) Market Report

Report Metric Details
Report Name Albumin (as Excipient) Market
CAGR 6.1%
Segment by Type
  • Human Serum Albumin
  • Recombinant Albumin
Segment by Application
  • Cell Culture Media
  • Medical Supplements
  • Therapeutics
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Albumin (as Excipient) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Albumin (as Excipient) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Albumin (as Excipient) sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Grifols share in Albumin (as Excipient) Market?

Ans: The industry"s leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.

What is the Albumin (as Excipient) Market share by region?

Ans: By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.

Who are the main players in the Albumin (as Excipient) Market report?

Ans: The main players in the Albumin (as Excipient) Market are CSL, Grifols, Takeda, Octapharma, Hualan Bio, CBPO, Shanghai RAAS, Kedrion, LFB Group, Albumedix, Biotest, Merck, Ventria (InVitria), HiMedia

What are the Application segmentation covered in the Albumin (as Excipient) Market report?

Ans: The Applications covered in the Albumin (as Excipient) Market report are Cell Culture Media, Medical Supplements, Therapeutics

What are the Type segmentation covered in the Albumin (as Excipient) Market report?

Ans: The Types covered in the Albumin (as Excipient) Market report are Human Serum Albumin, Recombinant Albumin

1 Study Coverage
1.1 Albumin (as Excipient) Product Introduction
1.2 Market by Type
1.2.1 Global Albumin (as Excipient) Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Human Serum Albumin
1.2.3 Recombinant Albumin
1.3 Market by Application
1.3.1 Global Albumin (as Excipient) Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Therapeutics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Albumin (as Excipient) Market Size Estimates and Forecasts
2.1.1 Global Albumin (as Excipient) Revenue 2020-2031
2.1.2 Global Albumin (as Excipient) Sales 2020-2031
2.2 Albumin (as Excipient) Market Size by Region: 2024 Versus 2031
2.3 Albumin (as Excipient) Sales by Region (2020-2031)
2.3.1 Global Albumin (as Excipient) Sales by Region: 2020-2025
2.3.2 Global Albumin (as Excipient) Sales Forecast by Region (2026-2031)
2.3.3 Global Albumin (as Excipient) Sales Market Share by Region (2020-2031)
2.4 Albumin (as Excipient) Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Albumin (as Excipient) Revenue by Region: 2020-2025
2.4.2 Global Albumin (as Excipient) Revenue Forecast by Region (2026-2031)
2.4.3 Global Albumin (as Excipient) Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Albumin (as Excipient) Sales by Type (2020-2031)
3.1.1.1 Global Albumin (as Excipient) Sales Volume by Type (2020-2031)
3.1.1.2 Global Albumin (as Excipient) Sales Market Share by Type (2020-2031)
3.1.2 Global Albumin (as Excipient) Revenue by Type (2020-2031)
3.1.2.1 Global Albumin (as Excipient) Revenue by Type (2020-2031)
3.1.2.2 Global Albumin (as Excipient) Revenue Market Share by Type (2020-2031)
3.1.3 Albumin (as Excipient) Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Albumin (as Excipient) Sales by Application (2020-2031)
3.2.1.1 Global Albumin (as Excipient) Sales Volume by Application (2020-2031)
3.2.1.2 Global Albumin (as Excipient) Sales Market Share by Application (2020-2031)
3.2.2 Global Albumin (as Excipient) Revenue by Application (2020-2031)
3.2.2.1 Global Albumin (as Excipient) Revenue by Application (2020-2031)
3.2.2.2 Global Albumin (as Excipient) Revenue Market Share by Application (2020-2031)
3.2.3 Albumin (as Excipient) Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Human Serum Albumin of Albumin (as Excipient) Revenue Market Share by Application
3.3.2 Recombinant Albumin of Albumin (as Excipient) Revenue Market Share by Application
4 Global Albumin (as Excipient) by Manufacturers
4.1 Global Top Albumin (as Excipient) Manufacturers by Sales (2020-2025)
4.1.1 Global Albumin (as Excipient) Sales by Manufacturer (2020-2025)
4.1.2 Global Albumin (as Excipient) Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Albumin (as Excipient) Manufacturers by Revenue (2020-2025)
4.2.1 Global Albumin (as Excipient) Revenue by Manufacturer (2020-2025)
4.2.2 Global Albumin (as Excipient) Revenue Share by Manufacturer (2020-2025)
4.3 Global Albumin (as Excipient) Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Albumin (as Excipient) Manufacturers Covered: Ranking by Revenue
4.4.2 Global Albumin (as Excipient) Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Albumin (as Excipient) Manufacturing Base Distribution, Product Type
4.5.1 Albumin (as Excipient) Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Albumin (as Excipient) Market
4.5.3 Manufacturers Albumin (as Excipient) Product Type and Application
4.5.4 Human Serum Albumin Market Sales of Albumin (as Excipient) by Manufacturer
4.5.5 Recombinant Albumin Market Sales of Albumin (as Excipient) by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 CSL
5.1.1 CSL Company Information
5.1.2 CSL Description, Business Overview
5.1.3 CSL Albumin (as Excipient) Products Offered
5.1.4 CSL Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.1.5 CSL Albumin (as Excipient) Sales by Product in 2024
5.1.6 CSL Albumin (as Excipient) Sales by Application in 2024
5.1.7 CSL Albumin (as Excipient) Sales by Geographic Area in 2024
5.1.8 CSL Recent Developments
5.2 Grifols
5.2.1 Grifols Company Information
5.2.2 Grifols Description, Business Overview
5.2.3 Grifols Albumin (as Excipient) Products Offered
5.2.4 Grifols Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Grifols Albumin (as Excipient) Sales by Product in 2024
5.2.6 Grifols Albumin (as Excipient) Sales by Application in 2024
5.2.7 Grifols Albumin (as Excipient) Sales by Geographic Area in 2024
5.2.8 Grifols Recent Developments
5.3 Takeda
5.3.1 Takeda Company Information
5.3.2 Takeda Description, Business Overview
5.3.3 Takeda Albumin (as Excipient) Products Offered
5.3.4 Takeda Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Takeda Albumin (as Excipient) Sales by Product in 2024
5.3.6 Takeda Albumin (as Excipient) Sales by Application in 2024
5.3.7 Takeda Albumin (as Excipient) Sales by Geographic Area in 2024
5.3.8 Takeda Recent Developments
5.4 Octapharma
5.4.1 Octapharma Company Information
5.4.2 Octapharma Description, Business Overview
5.4.3 Octapharma Albumin (as Excipient) Products Offered
5.4.4 Octapharma Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Octapharma Albumin (as Excipient) Sales by Product in 2024
5.4.6 Octapharma Albumin (as Excipient) Sales by Application in 2024
5.4.7 Octapharma Albumin (as Excipient) Sales by Geographic Area in 2024
5.4.8 Octapharma Recent Developments
5.5 Hualan Bio
5.5.1 Hualan Bio Company Information
5.5.2 Hualan Bio Description, Business Overview
5.5.3 Hualan Bio Albumin (as Excipient) Products Offered
5.5.4 Hualan Bio Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Hualan Bio Albumin (as Excipient) Sales by Product in 2024
5.5.6 Hualan Bio Albumin (as Excipient) Sales by Application in 2024
5.5.7 Hualan Bio Albumin (as Excipient) Sales by Geographic Area in 2024
5.5.8 Hualan Bio Recent Developments
5.6 CBPO
5.6.1 CBPO Company Information
5.6.2 CBPO Description, Business Overview
5.6.3 CBPO Albumin (as Excipient) Products Offered
5.6.4 CBPO Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.6.5 CBPO Albumin (as Excipient) Sales by Product in 2024
5.6.6 CBPO Albumin (as Excipient) Sales by Application in 2024
5.6.7 CBPO Albumin (as Excipient) Sales by Geographic Area in 2024
5.6.8 CBPO Recent Developments
5.7 Shanghai RAAS
5.7.1 Shanghai RAAS Company Information
5.7.2 Shanghai RAAS Description, Business Overview
5.7.3 Shanghai RAAS Albumin (as Excipient) Products Offered
5.7.4 Shanghai RAAS Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Shanghai RAAS Albumin (as Excipient) Sales by Product in 2024
5.7.6 Shanghai RAAS Albumin (as Excipient) Sales by Application in 2024
5.7.7 Shanghai RAAS Albumin (as Excipient) Sales by Geographic Area in 2024
5.7.8 Shanghai RAAS Recent Developments
5.8 Kedrion
5.8.1 Kedrion Company Information
5.8.2 Kedrion Description, Business Overview
5.8.3 Kedrion Albumin (as Excipient) Products Offered
5.8.4 Kedrion Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Kedrion Albumin (as Excipient) Sales by Product in 2024
5.8.6 Kedrion Albumin (as Excipient) Sales by Application in 2024
5.8.7 Kedrion Albumin (as Excipient) Sales by Geographic Area in 2024
5.8.8 Kedrion Recent Developments
5.9 LFB Group
5.9.1 LFB Group Company Information
5.9.2 LFB Group Description, Business Overview
5.9.3 LFB Group Albumin (as Excipient) Products Offered
5.9.4 LFB Group Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.9.5 LFB Group Albumin (as Excipient) Sales by Product in 2024
5.9.6 LFB Group Albumin (as Excipient) Sales by Application in 2024
5.9.7 LFB Group Albumin (as Excipient) Sales by Geographic Area in 2024
5.9.8 LFB Group Recent Developments
5.10 Albumedix
5.10.1 Albumedix Company Information
5.10.2 Albumedix Description, Business Overview
5.10.3 Albumedix Albumin (as Excipient) Products Offered
5.10.4 Albumedix Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Albumedix Albumin (as Excipient) Sales by Product in 2024
5.10.6 Albumedix Albumin (as Excipient) Sales by Application in 2024
5.10.7 Albumedix Albumin (as Excipient) Sales by Geographic Area in 2024
5.10.8 Albumedix Recent Developments
5.11 Biotest
5.11.1 Biotest Company Information
5.11.2 Biotest Description, Business Overview
5.11.3 Biotest Albumin (as Excipient) Products Offered
5.11.4 Biotest Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Biotest Albumin (as Excipient) Sales by Product in 2024
5.11.6 Biotest Albumin (as Excipient) Sales by Application in 2024
5.11.7 Biotest Albumin (as Excipient) Sales by Geographic Area in 2024
5.11.8 Biotest Recent Developments
5.12 Merck
5.12.1 Merck Company Information
5.12.2 Merck Description, Business Overview
5.12.3 Merck Albumin (as Excipient) Products Offered
5.12.4 Merck Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.12.5 Merck Albumin (as Excipient) Sales by Product in 2024
5.12.6 Merck Albumin (as Excipient) Sales by Application in 2024
5.12.7 Merck Albumin (as Excipient) Sales by Geographic Area in 2024
5.12.8 Merck Recent Developments
5.13 Ventria (InVitria)
5.13.1 Ventria (InVitria) Company Information
5.13.2 Ventria (InVitria) Description, Business Overview
5.13.3 Ventria (InVitria) Albumin (as Excipient) Products Offered
5.13.4 Ventria (InVitria) Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.13.5 Ventria (InVitria) Albumin (as Excipient) Sales by Product in 2024
5.13.6 Ventria (InVitria) Albumin (as Excipient) Sales by Application in 2024
5.13.7 Ventria (InVitria) Albumin (as Excipient) Sales by Geographic Area in 2024
5.13.8 Ventria (InVitria) Recent Developments
5.14 HiMedia
5.14.1 HiMedia Company Information
5.14.2 HiMedia Description, Business Overview
5.14.3 HiMedia Albumin (as Excipient) Products Offered
5.14.4 HiMedia Albumin (as Excipient) Sales, Revenue and Gross Margin (2020-2025)
5.14.5 HiMedia Albumin (as Excipient) Sales by Product in 2024
5.14.6 HiMedia Albumin (as Excipient) Sales by Application in 2024
5.14.7 HiMedia Albumin (as Excipient) Sales by Geographic Area in 2024
5.14.8 HiMedia Recent Developments
6 North America
6.1 North America Albumin (as Excipient) Market Size YoY Growth 2020-2031
6.2 North America Albumin (as Excipient) Market Facts & Figures by Country
6.2.1 North America Albumin (as Excipient) Sales by Country (2020-2031)
6.2.2 North America Albumin (as Excipient) Revenue by Country (2020-2031)
6.3 North America Albumin (as Excipient) Sales by Type (2020-2025)
6.4 North America Albumin (as Excipient) Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Albumin (as Excipient) Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Albumin (as Excipient) Market Facts & Figures by Region
7.2.1 Asia-Pacific Albumin (as Excipient) Sales by Region (2020-2031)
7.2.2 Asia-Pacific Albumin (as Excipient) Revenue by Region (2020-2031)
7.3 Asia-Pacific Albumin (as Excipient) Sales by Type (2020-2025)
7.4 Asia-Pacific Albumin (as Excipient) Sales by Application (2020-2025)
8 Europe
8.1 Europe Albumin (as Excipient) Market Size YoY Growth 2020-2031
8.2 Europe Albumin (as Excipient) Market Facts & Figures by Country
8.2.1 Europe Albumin (as Excipient) Sales by Country (2020-2031)
8.2.2 Europe Albumin (as Excipient) Revenue by Country (2020-2031)
8.3 Europe Albumin (as Excipient) Sales by Type (2020-2025)
8.4 Europe Albumin (as Excipient) Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Albumin (as Excipient) Market Size YoY Growth 2020-2031
9.2 Latin America Albumin (as Excipient) Market Facts & Figures by Country
9.2.1 Latin America Albumin (as Excipient) Sales by Country (2020-2031)
9.2.2 Latin America Albumin (as Excipient) Revenue by Country (2020-2031)
9.3 Latin America Albumin (as Excipient) Sales by Type (2020-2025)
9.4 Latin America Albumin (as Excipient) Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Albumin (as Excipient) Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Albumin (as Excipient) Market Facts & Figures by Country
10.2.1 Middle East and Africa Albumin (as Excipient) Sales by Country (2020-2031)
10.2.2 Middle East and Africa Albumin (as Excipient) Revenue by Country (2020-2031)
10.3 Middle East and Africa Albumin (as Excipient) Sales by Type (2020-2025)
10.4 Middle East and Africa Albumin (as Excipient) Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Albumin (as Excipient) Supply Chain Analysis
11.2 Albumin (as Excipient) Key Raw Materials and Upstream Suppliers
11.3 Albumin (as Excipient) Clients Analysis
11.4 Albumin (as Excipient) Sales Channel and Sales Model Analysis
11.4.1 Albumin (as Excipient) Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Albumin (as Excipient) Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Albumin (as Excipient) Distributors
12 Albumin (as Excipient) Market Dynamics
12.1 Albumin (as Excipient) Industry Trends
12.2 Albumin (as Excipient) Market Drivers
12.3 Albumin (as Excipient) Market Challenges
12.4 Albumin (as Excipient) Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
CSL Limited
Grifols S A
Octapharma AG
Hualan Bio
CBPO
Shanghai Raas
Kedrion S p A
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
Himedia
Takeda
List of Tables
 Table 1. Global Albumin (as Excipient) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Albumin (as Excipient) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Albumin (as Excipient) Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Albumin (as Excipient) Sales by Region (2020-2025) & (MT)
 Table 5. Global Albumin (as Excipient) Sales Forecast by Region (2026-2031) & (MT)
 Table 6. Global Albumin (as Excipient) Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Albumin (as Excipient) Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Albumin (as Excipient) Sales Volume by Type (2020-2025) & (MT)
 Table 9. Global Albumin (as Excipient) Sales Volume by Type (2026-2031) & (MT)
 Table 10. Global Albumin (as Excipient) Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Albumin (as Excipient) Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Albumin (as Excipient) Sales Volume by Application (2020-2025) & (MT)
 Table 13. Global Albumin (as Excipient) Sales Volume by Application (2026-2031) & (MT)
 Table 14. Global Albumin (as Excipient) Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Albumin (as Excipient) Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Albumin (as Excipient) Sales by Manufacturer (2020-2025) & (MT)
 Table 17. Global Albumin (as Excipient) Sales Share by Manufacturer (2020-2025)
 Table 18. Albumin (as Excipient) Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Albumin (as Excipient) Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Albumin (as Excipient) Price (2020-2025) & (USD/Kg)
 Table 21. Ranking of Global Top Albumin (as Excipient) Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Albumin (as Excipient) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Albumin (as Excipient) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Albumin (as Excipient) as of 2024)
 Table 24. Albumin (as Excipient) Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Albumin (as Excipient) Market
 Table 26. Manufacturers Albumin (as Excipient) Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. CSL Company Information
 Table 29. CSL Description and Business Overview
 Table 30. CSL Albumin (as Excipient) Product
 Table 31. CSL Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 32. CSL Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 33. CSL Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 34. CSL Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 35. CSL Recent Developments
 Table 36. Grifols Company Information
 Table 37. Grifols Description and Business Overview
 Table 38. Grifols Albumin (as Excipient) Product
 Table 39. Grifols Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 40. Grifols Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 41. Grifols Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 42. Grifols Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 43. Grifols Recent Developments
 Table 44. Takeda Company Information
 Table 45. Takeda Description and Business Overview
 Table 46. Takeda Albumin (as Excipient) Product
 Table 47. Takeda Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 48. Takeda Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 49. Takeda Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 50. Takeda Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 51. Takeda Recent Developments
 Table 52. Octapharma Company Information
 Table 53. Octapharma Description and Business Overview
 Table 54. Octapharma Albumin (as Excipient) Product
 Table 55. Octapharma Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 56. Octapharma Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 57. Octapharma Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 58. Octapharma Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 59. Octapharma Recent Developments
 Table 60. Hualan Bio Company Information
 Table 61. Hualan Bio Description and Business Overview
 Table 62. Hualan Bio Albumin (as Excipient) Product
 Table 63. Hualan Bio Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 64. Hualan Bio Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 65. Hualan Bio Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 66. Hualan Bio Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 67. Hualan Bio Recent Developments
 Table 68. CBPO Company Information
 Table 69. CBPO Description and Business Overview
 Table 70. CBPO Albumin (as Excipient) Product
 Table 71. CBPO Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 72. CBPO Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 73. CBPO Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 74. CBPO Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 75. CBPO Recent Developments
 Table 76. Shanghai RAAS Company Information
 Table 77. Shanghai RAAS Description and Business Overview
 Table 78. Shanghai RAAS Albumin (as Excipient) Product
 Table 79. Shanghai RAAS Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 80. Shanghai RAAS Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 81. Shanghai RAAS Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 82. Shanghai RAAS Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 83. Shanghai RAAS Recent Developments
 Table 84. Kedrion Company Information
 Table 85. Kedrion Description and Business Overview
 Table 86. Kedrion Albumin (as Excipient) Product
 Table 87. Kedrion Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 88. Kedrion Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 89. Kedrion Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 90. Kedrion Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 91. Kedrion Recent Developments
 Table 92. LFB Group Company Information
 Table 93. LFB Group Description and Business Overview
 Table 94. LFB Group Albumin (as Excipient) Product
 Table 95. LFB Group Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 96. LFB Group Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 97. LFB Group Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 98. LFB Group Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 99. LFB Group Recent Developments
 Table 100. Albumedix Company Information
 Table 101. Albumedix Description and Business Overview
 Table 102. Albumedix Albumin (as Excipient) Product
 Table 103. Albumedix Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 104. Albumedix Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 105. Albumedix Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 106. Albumedix Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 107. Albumedix Recent Developments
 Table 108. Biotest Company Information
 Table 109. Biotest Description and Business Overview
 Table 110. Biotest Albumin (as Excipient) Product
 Table 111. Biotest Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 112. Biotest Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 113. Biotest Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 114. Biotest Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 115. Biotest Recent Developments
 Table 116. Merck Company Information
 Table 117. Merck Description and Business Overview
 Table 118. Merck Albumin (as Excipient) Product
 Table 119. Merck Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 120. Merck Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 121. Merck Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 122. Merck Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 123. Merck Recent Developments
 Table 124. Ventria (InVitria) Company Information
 Table 125. Ventria (InVitria) Description and Business Overview
 Table 126. Ventria (InVitria) Albumin (as Excipient) Product
 Table 127. Ventria (InVitria) Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 128. Ventria (InVitria) Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 129. Ventria (InVitria) Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 130. Ventria (InVitria) Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 131. Ventria (InVitria) Recent Developments
 Table 132. HiMedia Company Information
 Table 133. HiMedia Description and Business Overview
 Table 134. HiMedia Albumin (as Excipient) Product
 Table 135. HiMedia Albumin (as Excipient) Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
 Table 136. HiMedia Sales Proportion of Albumin (as Excipient) by Product in 2024
 Table 137. HiMedia Sales Proportion of Albumin (as Excipient) by Application in 2024
 Table 138. HiMedia Sales Proportion of Albumin (as Excipient) by Geographic Area in 2024
 Table 139. HiMedia Recent Developments
 Table 140. North America Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
 Table 141. North America Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
 Table 142. North America Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
 Table 143. North America Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
 Table 144. North America Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
 Table 145. North America Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
 Table 146. Asia-Pacific Albumin (as Excipient) Sales by Region (2020-2025) & (MT)
 Table 147. Asia-Pacific Albumin (as Excipient) Sales by Region (2026-2031) & (MT)
 Table 148. Asia-Pacific Albumin (as Excipient) Revenue by Region (2020-2025) & (US$ Million)
 Table 149. Asia-Pacific Albumin (as Excipient) Revenue by Region (2026-2031) & (US$ Million)
 Table 150. Asia-Pacific Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
 Table 151. Asia-Pacific Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
 Table 152. Europe Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
 Table 153. Europe Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
 Table 154. Europe Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
 Table 155. Europe Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
 Table 156. Europe Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
 Table 157. Europe Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
 Table 158. Latin America Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
 Table 159. Latin America Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
 Table 160. Latin America Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
 Table 161. Latin America Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
 Table 162. Latin America Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
 Table 163. Latin America Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
 Table 164. Middle East and Africa Albumin (as Excipient) Sales by Country (2020-2025) & (MT)
 Table 165. Middle East and Africa Albumin (as Excipient) Sales by Country (2026-2031) & (MT)
 Table 166. Middle East and Africa Albumin (as Excipient) Revenue by Country (2020-2025) & (US$ Million)
 Table 167. Middle East and Africa Albumin (as Excipient) Revenue by Country (2026-2031) & (US$ Million)
 Table 168. Middle East and Africa Albumin (as Excipient) Sales by Type (2020-2025) & (MT)
 Table 169. Middle East and Africa Albumin (as Excipient) Sales by Application (2020-2025) & (MT)
 Table 170. Albumin (as Excipient) Key Raw Materials, Industry Status and Trend
 Table 171. Albumin (as Excipient) Key Raw Materials and Upstream Suppliers
 Table 172. Albumin (as Excipient) Clients Status and Trend
 Table 173. Albumin (as Excipient) Typical Clients
 Table 174. Albumin (as Excipient) Distributors
 Table 175. Albumin (as Excipient) Market Trends
 Table 176. Albumin (as Excipient) Market Drivers
 Table 177. Albumin (as Excipient) Market Challenges
 Table 178. Albumin (as Excipient) Market Restraints
 Table 179. Research Programs/Design for This Report
 Table 180. Key Data Information from Secondary Sources
 Table 181. Key Data Information from Primary Sources
 Table 182. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Albumin (as Excipient) Product Picture
 Figure 2. Global Albumin (as Excipient) Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Albumin (as Excipient) Sales Market Share by Type in 2024 & 2031
 Figure 4. Human Serum Albumin Product Picture
 Figure 5. Recombinant Albumin Product Picture
 Figure 6. Global Albumin (as Excipient) Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Albumin (as Excipient) Sales Market Share by Application in 2024 & 2031
 Figure 8. Cell Culture Media
 Figure 9. Medical Supplements
 Figure 10. Therapeutics
 Figure 11. Albumin (as Excipient) Report Years Considered
 Figure 12. Global Albumin (as Excipient) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Albumin (as Excipient) Market Size 2020-2031 (US$ Million)
 Figure 14. Global Albumin (as Excipient) Sales 2020-2031 (MT)
 Figure 15. Global Albumin (as Excipient) Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Albumin (as Excipient) Revenue Market Share by Region (2020-2031)
 Figure 17. Global Albumin (as Excipient) Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Albumin (as Excipient) Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Albumin (as Excipient) Average Selling Price (ASP) by Type (2020-2025) & (USD/Kg)
 Figure 20. Global Albumin (as Excipient) Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Albumin (as Excipient) Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Albumin (as Excipient) Average Selling Price (ASP) by Application (2020-2025) & (USD/Kg)
 Figure 23. Human Serum Albumin of Albumin (as Excipient) Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Recombinant Albumin of Albumin (as Excipient) Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Albumin (as Excipient) Sales Share by Manufacturer in 2024
 Figure 26. Albumin (as Excipient) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Human Serum Albumin Market Sales Proportion by Manufacturer in 2024
 Figure 28. Recombinant Albumin Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Albumin (as Excipient) Revenue 2020-2031 (US$ Million)
 Figure 30. North America Albumin (as Excipient) Sales Market Share by Type (2020-2025)
 Figure 31. North America Albumin (as Excipient) Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Albumin (as Excipient) Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Albumin (as Excipient) Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Albumin (as Excipient) Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Albumin (as Excipient) Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Albumin (as Excipient) Sales Market Share by Application (2020-2025)
 Figure 37. Europe Albumin (as Excipient) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Albumin (as Excipient) Sales Market Share by Country (2020-2031)
 Figure 39. Europe Albumin (as Excipient) Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Albumin (as Excipient) Sales Market Share by Type (2020-2025)
 Figure 41. Europe Albumin (as Excipient) Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Albumin (as Excipient) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Albumin (as Excipient) Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Albumin (as Excipient) Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Albumin (as Excipient) Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Albumin (as Excipient) Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Albumin (as Excipient) Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Albumin (as Excipient) Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Albumin (as Excipient) Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Albumin (as Excipient) Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Albumin (as Excipient) Sales Market Share by Application (2020-2025)
 Figure 52. Albumin (as Excipient) Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Albumin (as Excipient) Raw Materials by Region in 2024
 Figure 54. Albumin (as Excipient) Distribution Channels
 Figure 55. Global Albumin (as Excipient) Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Albumin (as Excipient) Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Albumin Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Excipient Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Plasma Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Serum Albumin Market Research Report 2025
Blood Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Albumin Market Research Report 2025
Global Albumin Pharmaceutical Preparations Market Research Report 2024
Global rHu Albumin Market Research Report 2024
Global Blood Banking and Blood Products Market Research Report 2024
Global Human Albumin Solution Market Research Report 2024
Global Albumin Testing Market Research Report 2024
Dry Bovine Serum Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Colloids Blood Plasma Market Research Report 2025
Human Albumin Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Serum Albumin Fusion Protein Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma Protein Products Market Research Report 2024
Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Globular Protein Market Insights Forecast to 2030
Global Glycated Albumin Market Insights Forecast to 2030
Global Human Plasma Protein Products Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions